in vitro PHARMACOLOGY 2011 CATALOG - Cerep
in vitro PHARMACOLOGY 2011 CATALOG - Cerep
in vitro PHARMACOLOGY 2011 CATALOG - Cerep
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
178 <strong>in</strong> <strong>vitro</strong> pharmacology <strong>2011</strong> catalog<br />
❚ arachidonic acid metabolism<br />
15-lipoxygenase<br />
Source<br />
soybean<br />
Substrate<br />
arachidonic acid (35 µM)<br />
❚ lipoxygenase<br />
Measured product ferric oxidation of xylenol orange<br />
Ref. 0190<br />
Detection method photometry<br />
Q 3 weeks<br />
Reference<br />
NDGA (IC 50 : 1.1 µM)<br />
Included <strong>in</strong>:<br />
Organ safety profile<br />
Waslidge, N.B. and Hayes, D.J. (1995) Anal. biochem., 231: 354-358.<br />
enzyme activity (% of control)<br />
100<br />
50<br />
0<br />
-8 -7 -6 -5 -4<br />
log [drug] (M)<br />
NDGA<br />
COX 1<br />
❚ cyclooxigenase<br />
Ref. 0726<br />
Q 3 weeks<br />
Included <strong>in</strong>:<br />
Non-k<strong>in</strong>ase enzyme profile<br />
BioPr<strong>in</strong>t ® profile<br />
Source<br />
Substrate<br />
Measured product PGE 2<br />
Detection method EIA<br />
Reference<br />
human recomb<strong>in</strong>ant (Sf9 cells)<br />
arachidonic acid (4 µM)<br />
diclofenac (IC 50 : 13 nM)<br />
Glaser, K. et al. (1995) Eur. J. Pharmacol., 281: 107-111.<br />
enzyme activity (% of control)<br />
100<br />
-10 -9 -8 -7 -6 -5 -4<br />
50<br />
-11 -10 -9 -8 -7 -6<br />
-12 -11 -10 -7 -6<br />
-9 -8<br />
diclofenac<br />
0<br />
sul<strong>in</strong>dac<br />
<strong>in</strong>domethac<strong>in</strong>e<br />
-11 -10 -9 -8 -7 -6 -5<br />
log [drug] (M)<br />
COX 2<br />
❚ cyclooxigenase<br />
Ref. 0727<br />
Q 3 weeks<br />
Included <strong>in</strong>:<br />
Non-k<strong>in</strong>ase enzyme profile<br />
BioPr<strong>in</strong>t ® profile<br />
Organ safety profile<br />
Source<br />
human recomb<strong>in</strong>ant (Sf9 cells)<br />
Substrate<br />
arachidonic acid (2 µM)<br />
Measured product PGE 2<br />
Detection method EIA<br />
Reference<br />
NS398 (IC 50 : 68 nM)<br />
Glaser, K. et al. (1995) Eur. J. Pharmacol., 281: 107-111.<br />
enzyme activity (% of control)<br />
100<br />
-10 -9 -8 -7 -6 -5 -4<br />
50 -11 -10 -9 -8 -7 -6<br />
-12 -11 -10 -6<br />
-9 -8 -7<br />
NS 398<br />
diclofenac<br />
rofecoxib<br />
0<br />
<strong>in</strong>domethac<strong>in</strong>e<br />
-10 -9 -8 -7 -6 -5 -4<br />
log [drug] (M)<br />
sPLA 2 (Type V)<br />
❚ phospholipase<br />
Ref. 3176<br />
Q 3 weeks<br />
Included <strong>in</strong>:<br />
Non-k<strong>in</strong>ase enzyme profile<br />
Organ safety profile<br />
Source<br />
Substrate<br />
Measured product<br />
Detection method<br />
human recomb<strong>in</strong>ant (E. coli)<br />
diheptanoyl thio-PC (250 µM)<br />
heptanoyl thio-PC<br />
photometry<br />
Reference<br />
oleyloxyethyl phosphorylchol<strong>in</strong>e<br />
(IC 50 : 20 µM)<br />
Tiege, U.J. et al. (2005) J. Lipid. Res., 46: 1604-1614.<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
sPLA 2 (bee venom type III)<br />
❚ phospholipase<br />
Ref. 2999<br />
Q 3 weeks<br />
Source<br />
Substrate<br />
Measured product<br />
Detection method<br />
Reference<br />
bee venom<br />
diheptanoyl thio-PC (250 µM)<br />
heptanoyl thio-PC<br />
photometry<br />
oleyloxyethyl phosphorylchol<strong>in</strong>e<br />
(IC 50 : 5.7 µM)<br />
Tiege, U.J. et al. (2005) J. Lipid. Res., 46: 1604-1614.<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
TXA 2 synthetase<br />
❚ TXA 2 synthetase<br />
Ref. 0564<br />
Q 3 weeks<br />
Source<br />
human platelets<br />
Substrate<br />
PGH 2 (10 µM)<br />
Measured product TXB 2<br />
Detection method EIA<br />
Reference<br />
furegrelate (IC 50 : 6 nM)<br />
Wade, M.L. and Fitzpatrick, F.A. (1997) Arch. Biochem. Biophys., 347: 174-180.<br />
enzyme activity (% of control)<br />
<br />
100<br />
<br />
<br />
<br />
50<br />
<br />
<br />
0<br />
furegrelate<br />
<br />
<br />
-9 -8 -7 -6 -5<br />
-11 -10<br />
log [drug] (M)